Study Evaluating Isovorin in Advanced/Recurrent Gastric Cancer

NCT00195572 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastric Cancer

Interventions

DRUG: Isovorin
DRUG: TS-1

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer